Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 251-439-1 | (3β,5β)-3-[(O-β-D-glucopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide | 33279-57-1 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 2 | H300 | H300 |
GHS06 Dgr |
38 | View details | ||||||
| Acute Tox. 2 | H310 | H310 | |||||||||
| Acute Tox. 1 | H330 | H330 | |||||||||
| Acute Tox. 3 | H301 | H301 |
GHS08 GHS06 Dgr |
State/Form
|
2 | View details | |||||
| Acute Tox. 3 | H331 | H331 | |||||||||
| STOT RE 2 | H373 | H373 | |||||||||
Number of Aggregated Notifications: 2